Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Vogelzang

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer|December 14, 1999
The ongoing evolution of dendritic cell therapyM H Sokoloff, N Vogelzang
Oncology Reports|May 25, 2011
Phase-ii evaluation of single-agent Carboplatin in advanced thyroid-carcinomaS Ong, L Degroot, N Vogelzang
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1974
Herpes virus latency in spinal ganglia of mice without illnessR R McKendall, N Vogelzang, G G Jackson
Cancer|December 15, 1990
True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancyA Talerman, M S Verp, E Senekjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studiesD Bajorin, A Katz, E Chan, et al.
Seminars in Oncology|December 22, 1999
A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780D Savarese, M E Taplin, S Halabi, et al.
Journal of the American Academy of Dermatology|November 1, 1996
Interleukin-2 associated linear IgA bullous dermatosisA Tranvan, D S Pezen, M Medenica, et al.
Investigational New Drugs|August 1, 1991
Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641R L Schilsky, D Faraggi, A Korzun, et al.
Oncology Reports|May 25, 2011
Phase-I trial of Thiotepa, granulocyte-macrophage colony-stimulating factor and prednisone or pentoxifylline in patients with refractory solid tumorsS Devine, M Ratain, L Janisch, et al.
Cancer Treatment Reports|February 1, 1986
Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council StudyJ Harris, T Das Gupta, N Vogelzang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer|December 14, 1999
The ongoing evolution of dendritic cell therapyM H Sokoloff, N Vogelzang
Oncology Reports|May 25, 2011
Phase-ii evaluation of single-agent Carboplatin in advanced thyroid-carcinomaS Ong, L Degroot, N Vogelzang
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1974
Herpes virus latency in spinal ganglia of mice without illnessR R McKendall, N Vogelzang, G G Jackson
Cancer|December 15, 1990
True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancyA Talerman, M S Verp, E Senekjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studiesD Bajorin, A Katz, E Chan, et al.
Seminars in Oncology|December 22, 1999
A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: preliminary results of cancer and leukemia group B Trial 9780D Savarese, M E Taplin, S Halabi, et al.
Journal of the American Academy of Dermatology|November 1, 1996
Interleukin-2 associated linear IgA bullous dermatosisA Tranvan, D S Pezen, M Medenica, et al.
Investigational New Drugs|August 1, 1991
Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641R L Schilsky, D Faraggi, A Korzun, et al.
Oncology Reports|May 25, 2011
Phase-I trial of Thiotepa, granulocyte-macrophage colony-stimulating factor and prednisone or pentoxifylline in patients with refractory solid tumorsS Devine, M Ratain, L Janisch, et al.
Cancer Treatment Reports|February 1, 1986
Treatment of soft tissue sarcoma with fibroblast interferon (beta-interferon): an American Cancer Society/Illinois Cancer Council StudyJ Harris, T Das Gupta, N Vogelzang, et al.
Pageof 3